Consultations

We consult whenever we're considering funding a medicine. Your views are important and affect our decisions.

Open consultations

Proposal for new supply agreements for funded vaccines in the National Immunisation Schedule, and widened access to influenza vaccine

We are entering new supply arrangements for some funded vaccines. These changes will: guarantee continued supply of 17 funded vaccines and a diagnostic test widen access to a flu vaccine for children (from 6 months until their 5th birthday) widen access to pneumoccal vaccine for people who have had a serious pneumoccal infection.

Proposal for the supply of dapsone tablets

The current brand of dapsone 25 and 50 mg tablets is being discontinued. We have sourced another brand but it is only available as 50 mg and 100 mg tablets. Let us know how this change might affect you or people you know.

Show more

Closed consultations

  • Feedback on proposal to amend access criteria for type 2 diabetes medicines

    We sought your feedback on a proposal for people living with Type 2 diabetes and at risk of cardio-renal complications. We are proposing to widen access to: empagliflozin (Jardiance) empagliflozin with metformin (Jardiamet) dulaglutide (Trulicity) ...

    Closed 11 June 2026

  • Review of the Exceptional Circumstances Framework

    Pharmac is reviewing its Exceptional Circumstances Framework (the Framework) after people told us it needs to work better and is hard to understand. The Framework includes the Named Patient Pharmaceutical Assessment (NPPA) policy and other ways Pharmac can fund medicines for...

    Closed 7 June 2026

  • Operational Policy and Procedures Manual review

    We are updating our Operating Policies and Procedures Manual (the Manual) to bring it into line with the breadth of Pharmac’s current practices and the current health system. It was last updated in 2017. Downloads Proposed 2026 Manual [PDF, 597KB] Current 2017 Manual [PDF, 596KB]

    Closed 26 May 2026

  • Proposal to enter into an agreement for a range of medical devices supplied by Smith & Nephew

    Pharmac is seeking feedback on a proposal to enter into an agreement for a range of medical devices supplied by Smith & Nephew Limited (“Smith & Nephew”) in Part III of Section H of the Pharmaceutical Schedule from 1 July 2026 in the following categories: surgical implants ...

    Closed 25 May 2026

  • Possible brand changes through Pharmac's annual tender

    We are seeking feedback on possible brand changes for medicines in Pharmac’s annual tender.

    Closed 4 May 2026